NIH Grants in Proteomics, June 19 to August 24, Part 2 of 2 (Part 1 is available here.)

San Diego-based diagnostics startup Mane Cancer Diagnostics has formed its management team (see related story, this issue).

NOTE TO READERS: GenomeWeb Daily News will publish one bulletin on Monday, Sept. 3, in observance of Labor Day in the US. We will resume publishing twice-daily bulletins on Tuesday, Sept. 4.

NEW YORK (GenomeWeb News) – Researchers at George Washington University School of Medicine and Health Sciences and the University of Maryland School of Medicine will use a $405,000 grant from the National Institute on Drug Abuse to investigate genes that may increase susceptibility to drug abuse

NEW YORK (GenomeWeb News) – Idaho Technology has changed its name to BioFire Diagnostics.

NEW YORK (GenomeWeb News) – Roche said this week that it has appointed Daniel O'Day, current COO of Roche Diagnostics, to be COO of Roche Pharma, taking over for Pascal Soriot, who has left the firm to become CEO of AstraZeneca.

Siemens Healthcare Diagnostics this week introduced its new Innovance Free Protein S Antigen assay for free protein S antigen testing.

A former Harvard postdoc has been sanctioned for research misconduct.

Ryan Phelan is tackling extinction.

A blogger shares tips on snagging funding.

Researchers have discovered a molecular signature that reflects the internal body clock.

In Science this week: higher coverage of the Denisova genome, bendable DNA, and more.

NEW YORK (GenomeWeb News) – Mizuho Securities has initiated coverage of Fluidigm and BG Medicine, placing a Buy rating on both firms.

NEW YORK (GenomeWeb News) – Dow AgroSciences has struck a collaboration with Australia's Victoria Department of Primary Industries (DPI)to develop new genetics technologies to boost crop performance, the Dow Chemical subsidiary said this week.

The 2012 US Republican Party platform includes some positions on biomedical research.

In Nature this week: the role of two epigenetic modification factors in cell reprogramming, IDH1 gene mutation, and more.

A Nature survey finds that while researchers like their jobs, they have concerns about the future.

Ag-bio firms are taking an interest in RNAi.

Cepheid last week filed suit against Roche seeking to invalidate a pair of PCR patents owned by Roche.

Bio-Rad this week introduced qPCR assays and panels that have been wet-lab validated to meet the minimum information for publication of quantitative real-time PCR experiments, or MIQE, guidelines.

Finnish molecular diagnostics firm Abacus Diagnostica, fresh off winning a pair of key US patents covering its DNA testing technologies, plans to seek regulatory approval in the US next year for tests to detect Staphylococcus aureus and methicillin-resistant S.

Idaho Technology said yesterday that it has changed its name to BioFire Diagnostics. The Salt Lake City, Utah-based company said that the new name more accurately reflects its business strategy and "strong momentum in the marketplace."

Sigma-Aldrich this week released its KiCqStart Primers, a series of primer pairs designed to quantify gene expression using two-step or one-step SYBR Green I qPCR.

NEW YORK (GenomeWeb News) – Med BioGene on Thursday reported that it swung to a loss from a profit for the first half of 2012.

NEW YORK (GenomeWeb News) – Australian molecular diagnostics firm Genetic Technologies has filed a lawsuit against Chicago-based Reproductive Genetics Institute for alleged infringement of a patent covering its non-coding DNA technology.